Market Cap 299.59M
Revenue (ttm) 40.52M
Net Income (ttm) -160.06M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -395.01%
Debt to Equity Ratio 0.00
Volume 1,020,900
Avg Vol 1,603,882
Day's Range N/A - N/A
Shares Out 97.91M
Stochastic %K 24%
Beta 2.14
Analysts Sell
Price Target $5.66

Company Profile

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. Its lead program is EDIT-401, a one-time therapy designed to reduce LDL cholesterol through the upregulation of the LDL receptor to treat hyperlipidemia. The company also develops therapies to treat Sickle cell disease and transfusion-dependent beta thalasse...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 401 9000
Address:
11 Hurley Street, Cambridge, United States
0x126
0x126 May. 13 at 8:43 AM
$EDIT a woopsy, +9% pre-market?
0 · Reply
RedTop1
RedTop1 May. 11 at 2:20 PM
$EDIT Just need a little PR to get this jumping. Been accumulating in the 1000's of shrs!
1 · Reply
BillionerOfKing
BillionerOfKing May. 11 at 1:34 PM
$EDIT Current Stock Price: $3.21 Contracts to trade: $2.5 EDIT May 15 2026 Call Entry: $0.60 Exit: $0.81 ROI: 35% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
svertical1
svertical1 May. 9 at 5:20 AM
$CRSP Should be CRSP, $EDIT $NTLA https://x.com/agingroy/status/2052840682662793528?s=42&t=lVKGgcMdQmE679bIABPvLg
0 · Reply
Jami_JO
Jami_JO May. 8 at 5:15 PM
0 · Reply
NewEarth
NewEarth May. 8 at 2:34 PM
$NTLA $BEAM $EDIT $REGN $PRME Jennifer and Intellia are going to hold the market of all these treatments
0 · Reply
RocroBio
RocroBio May. 7 at 5:40 PM
0 · Reply
Sdwg
Sdwg May. 7 at 3:46 PM
$EDIT would be a miracle if some insiders would buy a few shares....must have option grants up the wazzoo...no mention of future licensing royalties in earning release...kind of a fail on managements part, no?
0 · Reply
harryvanluik
harryvanluik May. 5 at 2:14 PM
$EDIT https://finance.yahoo.com/sectors/healthcare/articles/editas-medicine-announces-first-quarter-110000665.html nothing really new, just confirmation that we are definitely sitting on the right flight to heaven.
0 · Reply
StockConsultant
StockConsultant May. 5 at 12:12 PM
$EDIT Editas Medicine stock watch, attempting to rally off the 2.99 support area at https://stockconsultant.com/?EDIT
1 · Reply
Latest News on EDIT
Editas Medicine reports Q1 EPS (26c), consensus (24c)

2026-05-05T11:49:57.000Z - 8 days ago

Editas Medicine reports Q1 EPS (26c), consensus (24c)


Editas Medicine upgraded to Buy from Hold at JonesResearch

2026-03-10T14:25:34.000Z - 2 months ago

Editas Medicine upgraded to Buy from Hold at JonesResearch


Editas Medicine reports Q4 EPS (6c), consensus (26c)

2026-03-09T11:05:44.000Z - 2 months ago

Editas Medicine reports Q4 EPS (6c), consensus (26c)


Editas Medicine to Participate in Upcoming Investor Conferences

Feb 23, 2026, 9:00 AM EST - 2 months ago

Editas Medicine to Participate in Upcoming Investor Conferences


Genflow Biosciences PLC Announces Directorate Change

Jan 19, 2026, 2:20 AM EST - 4 months ago

Genflow Biosciences PLC Announces Directorate Change


Editas Medicine reports Q3 EPS (28c), consensus (38c)

2025-11-10T12:20:51.000Z - 6 months ago

Editas Medicine reports Q3 EPS (28c), consensus (38c)


Editas Medicine management to meet with Cantor

2025-10-23T19:50:17.000Z - 7 months ago

Editas Medicine management to meet with Cantor


Editas Medicine Transcript: Status Update

Sep 2, 2025, 8:00 AM EDT - 9 months ago

Editas Medicine Transcript: Status Update


Editas Medicine Announces Chief Financial Officer Transition

Mar 20, 2025, 4:01 PM EDT - 1 year ago

Editas Medicine Announces Chief Financial Officer Transition


Editas Medicine Transcript: Strategy Update

Dec 12, 2024, 5:00 PM EST - 1 year ago

Editas Medicine Transcript: Strategy Update


Editas Medicine Transcript: Stifel 2024 Healthcare Conference

Nov 19, 2024, 1:50 PM EST - 1 year ago

Editas Medicine Transcript: Stifel 2024 Healthcare Conference


Editas Medicine Transcript: Strategy Update

Oct 22, 2024, 8:00 AM EDT - 1 year ago

Editas Medicine Transcript: Strategy Update


Editas Medicine Transcript: Strategy Update

Oct 22, 2024, 8:00 AM EDT - 1 year ago

Editas Medicine Transcript: Strategy Update


Editas Medicine Earnings Call Transcript: Q2 2024

Aug 7, 2024, 8:00 AM EDT - 1 year ago

Editas Medicine Earnings Call Transcript: Q2 2024


Editas Medicine Transcript: AGM 2024

May 30, 2024, 8:30 AM EDT - 2 years ago

Editas Medicine Transcript: AGM 2024


Editas Medicine Earnings Call Transcript: Q1 2024

May 8, 2024, 8:00 AM EDT - 2 years ago

Editas Medicine Earnings Call Transcript: Q1 2024


Editas Medicine Earnings Call Transcript: Q4 2023

Feb 28, 2024, 8:00 AM EST - 2 years ago

Editas Medicine Earnings Call Transcript: Q4 2023


Editas Medicine Transcript: Study Update

Dec 11, 2023, 1:00 PM EST - 2 years ago

Editas Medicine Transcript: Study Update


0x126
0x126 May. 13 at 8:43 AM
$EDIT a woopsy, +9% pre-market?
0 · Reply
RedTop1
RedTop1 May. 11 at 2:20 PM
$EDIT Just need a little PR to get this jumping. Been accumulating in the 1000's of shrs!
1 · Reply
BillionerOfKing
BillionerOfKing May. 11 at 1:34 PM
$EDIT Current Stock Price: $3.21 Contracts to trade: $2.5 EDIT May 15 2026 Call Entry: $0.60 Exit: $0.81 ROI: 35% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
svertical1
svertical1 May. 9 at 5:20 AM
$CRSP Should be CRSP, $EDIT $NTLA https://x.com/agingroy/status/2052840682662793528?s=42&t=lVKGgcMdQmE679bIABPvLg
0 · Reply
Jami_JO
Jami_JO May. 8 at 5:15 PM
0 · Reply
NewEarth
NewEarth May. 8 at 2:34 PM
$NTLA $BEAM $EDIT $REGN $PRME Jennifer and Intellia are going to hold the market of all these treatments
0 · Reply
RocroBio
RocroBio May. 7 at 5:40 PM
0 · Reply
Sdwg
Sdwg May. 7 at 3:46 PM
$EDIT would be a miracle if some insiders would buy a few shares....must have option grants up the wazzoo...no mention of future licensing royalties in earning release...kind of a fail on managements part, no?
0 · Reply
harryvanluik
harryvanluik May. 5 at 2:14 PM
$EDIT https://finance.yahoo.com/sectors/healthcare/articles/editas-medicine-announces-first-quarter-110000665.html nothing really new, just confirmation that we are definitely sitting on the right flight to heaven.
0 · Reply
StockConsultant
StockConsultant May. 5 at 12:12 PM
$EDIT Editas Medicine stock watch, attempting to rally off the 2.99 support area at https://stockconsultant.com/?EDIT
1 · Reply
ERadar
ERadar May. 4 at 11:46 PM
0 · Reply
0x126
0x126 May. 4 at 1:13 PM
0 · Reply
dkm11
dkm11 May. 4 at 12:24 PM
0 · Reply
juliano777
juliano777 May. 1 at 8:27 AM
$EDIT American Society of Gene and Cell Therapy (ASGCT) 2026 Annual Meeting, May 11-15 Oral Presentation: Title: Preclinical Development of EDIT-401, a Durable In Vivo CRISPR Gene Editing Therapy That Upregulates LDLR Protein to Lower LDL-C Session Date and Time: Thursday, May 14, 3:30 p.m. – 5:00 p.m. EDT Session Title: Gene Therapy for Cardiovascular Diseases Presentation Room: 206AB Final Abstract Number: 380 Poster Presentations: Title: Pharmacokinetics and Pharmacodynamics of In Vivo Gene Editing Therapy for Lowering LDL-C in Mice Session Date and Time: Thursday, May 14, 5:00 p.m. – 6:30 p.m. EDT Session Title: Thursday Poster Reception Presentation Room: Exhibit and Poster Hall Final Abstract Number: 3423
0 · Reply
juliano777
juliano777 May. 1 at 8:26 AM
$EDIT Title: In Vivo CRISPR-based Disruption of an Important Gene Repressor Element Upregulates a Compensatory Protein to Normalize Disease-Associated Biomarkers in a Knockout Mouse Disease Model Session Date and Time: Wednesday, May 13, 5:00 p.m. – 6:30 p.m. EDT Session Title: Wednesday Poster Reception Presentation Room: Exhibit and Poster Hall Final Abstract Number: 2324 TIDES USA 2026: Oligonucleotide and Peptide Therapeutics Conference, May 11-14 Oral Presentation: Title: Transformative LDL Cholesterol Lowering In Vivo CRISPR Gene Editing Approach for Hyperlipidemia and Atherosclerotic Cardiovascular Disease Session Date and Time: Wednesday, May 13, 8:30 a.m. – 9:00 a.m. EDT Session Title: mRNA & Genome Editing: Technology & Applications
0 · Reply
juliano777
juliano777 May. 1 at 8:25 AM
$EDIT 94th European Atherosclerosis Society (EAS) Congress, May 24-27 Oral Presentation: Title: A Transformative In Vivo CRISPR Gene Editing Medicine Upregulates LDLR and Meaningfully Reduces LDL-C in Non-Human Primates Session Date and Time: Monday, May 25, 3:45 p.m. – 5:15 p.m. EET/9:45 a.m. – 11:15 a.m. EDT Session Title: New Pathways for Lipid and Lipoprotein Metabolism Presentation Room: Nana Hall Final Abstract Number: 159 Abstracts can be accessed on the conference websites as they become available, and the presentations will be posted on the Editas Medicine website during the conferences.
0 · Reply
juliano777
juliano777 May. 1 at 8:23 AM
$EDIT The complete list of Editas Medicine presentations is below. American Society of Gene and Cell Therapy (ASGCT) 2026 Annual Meeting, May 11-15 Oral Presentation: Title: Preclinical Development of EDIT-401, a Durable In Vivo CRISPR Gene Editing Therapy That Upregulates LDLR Protein to Lower LDL-C Session Date and Time: Thursday, May 14, 3:30 p.m. – 5:00 p.m. EDT Session Title: Gene Therapy for Cardiovascular Diseases Presentation Room: 206AB Final Abstract Number: 380 Poster Presentations: Title: Pharmacokinetics and Pharmacodynamics of In Vivo Gene Editing Therapy for Lowering LDL-C in Mice Session Date and Time: Thursday, May 14, 5:00 p.m. – 6:30 p.m. EDT Session Title: Thursday Poster Reception Presentation Room: Exhibit and Poster Hall Final Abstract Number: 3423
0 · Reply
ERadar
ERadar Apr. 30 at 2:17 PM
$EDIT time to load this ship 🤙
0 · Reply
nUme22
nUme22 Apr. 29 at 8:25 PM
$EDIT 2 bucks
2 · Reply
ERadar
ERadar Apr. 29 at 8:07 PM
$EDIT love that drop! 🤙
0 · Reply
Whoami1989
Whoami1989 Apr. 29 at 6:21 PM
$EDIT this fpos has 30% haircut within few days. what is the worthless piece of shit
0 · Reply
MadRufus
MadRufus Apr. 29 at 5:36 PM
$EDIT It´s a matter of time but maaaan... these pump and downs really get to you.... I´ll keep holding , my time will come
0 · Reply